COMMUNITY-ACQUIRED PNEUMONIA: MODERN METHODS OF DIAGNOSIS, TREATMENT, AND REHABILITATION

Community-acquired pneumonia (CAP) remains one of the most prevalent infectious diseases worldwide and continues to represent a significant clinical and socioeconomic burden despite advances in diagnostic and therapeutic strategies. CAP affects patients of all age groups and is associated with considerable morbidity, mortality, prolonged hospitalization, and long-term functional impairment. The heterogeneity of etiological agents, variability in clinical presentation, and the growing challenge of antimicrobial resistance complicate timely diagnosis and effective management. The present study provides a comprehensive analysis of contemporary approaches to the diagnosis, treatment, and rehabilitation of patients with community-acquired pneumonia. Special attention is given to modern laboratory biomarkers, advanced imaging modalities, evidence-based antimicrobial regimens, and structured rehabilitation programs aimed at restoring pulmonary function and improving quality of life. Clinical and statistical data were generated and analyzed to evaluate disease severity, treatment outcomes, and recovery dynamics in patients with varying clinical presentations of CAP. The findings highlight that early diagnosis using combined clinical, laboratory, and imaging criteria significantly improves therapeutic outcomes. Rational antimicrobial therapy, guided by severity assessment and local resistance patterns, remains the cornerstone of treatment. Furthermore, post-acute rehabilitation plays a crucial role in reducing residual symptoms, preventing complications, and facilitating full functional recovery. An integrated, multidisciplinary approach is essential for optimizing both short-term and long-term outcomes in patients with community-acquired pneumonia.